Design of a new pH‐activatable cell‐penetrating peptide for drug delivery into tumor cells
- 6 May 2019
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 94 (5) , 1884-1893
Abstract
Cell‐penetrating peptides (CPPs) have been considered as potential drug delivery vectors due to their remarkable membrane translocation capacity. However, lack of specificity and extreme systemic toxicity hamper their successful application for drug delivery. Here, we designed a new pH‐activatable CPP, LHHLLHHLHHLLHH‐NH2 (LH), by substitution of all lysines and two leucines of LKKLLKLLKKLLKL‐NH2 (LK) with histidines. As expected, histidine‐rich LH could be activated and penetrate into cells at pH 6.0, whereas its membrane transduction activity could be shielded at pH 7.4. In contrast, LK showed no obviously different cellular uptake at both pH conditions. Importantly, LH was significantly less cytotoxicity compared with LK at both pH values, suggesting a better safety for further application. In addition, after conjugation of camptothecin (CPT) with LH, this conjugate displayed remarkably pH‐dependent antitumor activity than free CPT and LK‐CPT. This study provides a new tumor pH‐responsive CPP with low toxicity for selective anticancer drug delivery.Keywords
This publication has 33 references indexed in Scilit:
- Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapyBiotechnology Advances, 2014
- Structural Characterization of de Novo Designed L5K5W Model Peptide Isomers with Potent Antimicrobial and Varied Hemolytic ActivitiesMolecules, 2013
- Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug deliveryBiomaterials, 2012
- Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactionsProceedings of the National Academy of Sciences, 2011
- Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance PBioorganic & Medicinal Chemistry Letters, 2011
- pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferationProceedings of the National Academy of Sciences, 2010
- Secondary structure of cell-penetrating peptides controls membrane interaction and insertionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2010
- Cancer Genome Sequencing—An Interim AnalysisCancer Research, 2009
- Recent progress in tumor pH targeting nanotechnologyJournal of Controlled Release, 2008
- Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pHFEBS Letters, 2004